Source link : https://newshealth.biz/health-news/head-to-head-trial-supports-new-treatment-for-kids-with-ms/
A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary endpoint while suggesting potential safety advantages. Medscape Medical News Source link : https://www.medscape.com/viewarticle/head-head-trial-supports-new-treatment-children-multiple-2025a1000qjn?src=rss Author : Publish date : 2025-10-03 05:20:00 Copyright for syndicated content belongs to the linked Source.
The post Head-to-Head Trial Supports New Treatment for Kids With MS first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-03 05:20:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8